Saiid Zarrabian Insider Trading $KTRA Kintara Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Saiid Zarrabian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Saiid Zarrabian. Saiid Zarrabian is Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and Director in PENWEST PHARMACEUTICALS CO ($PPCO) and Director in DelMar Pharmaceuticals, Inc. ($DMPI) and Interim CEO in DelMar Pharmaceuticals, Inc. ($DMPI) and President and CEO in DelMar Pharmaceuticals, Inc. ($DMPI).
Saiid Zarrabian in Kintara Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Saiid Zarrabian: President and CEO, Interim CEO, Director
Holdings: 55,000 shares
Latest Transaction: Sep 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Saiid Zarrabian in Kintara Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KTRA, LJPC, PPCO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17 2020 | DMPI | Kintara Therapeuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 1.70 | 2,715,004 | 4,615,507 | 2,715,004 | |
| Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 241,438 | 147,277 | 457,650 | |
| Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 216,212 | 131,889 | 216,212 | |
| Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.61 | 241,438 | 147,277 | 241,438 | |
| May 01 2019 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
| May 22 2018 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | President and CEO | Option Exercise | A | 0.98 | 836,465 | 821,827 | 836,465 | |
| Nov 16 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Interim CEO | Buy | P | 0.84 | 5,900 | 4,956 | 5,900 | 0 to 5.9 K |
| Nov 16 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Interim CEO | Buy | P | 0.82 | 55,000 | 45,100 | 55,000 | 0 to 55 K |
| Nov 07 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Interim CEO | Option Exercise | A | 0.87 | 120,000 | 104,400 | 120,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 |
Page: 1